Skip to content
Find a Provider
Sharlin Varghese, M.B.B.S.

Sharlin Varghese, M.B.B.S.

UR Medicine Labs

No ratings currently available, see text in Ratings section below for explanation.

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Not Accepting New Patients

Contact

Office (585) 275-3191

About Me

Dr. Varghese is the director of Gynecologic Pathology at Strong Memorial Hospital and Highland Hospital. She has served as assistant professor and attending physician in surgical and cytopathology at the University of Rochester Medical Center since 2010.
Dr. Varghese is the director of Gynecologic Pathology at Strong Memorial Hospital and Highland Hospital. She has served as assistant professor and attending physician in surgical and cytopathology at the University of Rochester Medical Center since 2010.

Certified Specialties

Cytopathology - American Board of Pathology

Pathology, Anatomic Pathology & Clinical Pathology - American Board of Pathology

Faculty Appointments

Associate Professor (Part-Time) - Department of Pathology and Laboratory Medicine (SMD)

Credentials

Residency & Fellowship

Fellowship, Cytopathology, University of Rochester Medical Center. 2009 - 2010

Residency, Pathology, Anatomic Pathology & Clinical Pathology, University of Rochester Medical Center. 2006 - 2009

Internship, Pathology, Anatomic Pathology & Clinical Pathology, University of Rochester Medical Center. 2005 - 2006

Internship, Pathology, Kerala University-Kottayam Medical College (India). 2001 - 2003

Education

MBBS | TD Medical College, Alleppey (INDIA). 2000

Publications

Journal Articles

Effect of Thin Prep(®) imaging system on laboratory rate and relative sensitivity of atypical squamous cells, high-grade squamous intraepithelial lesion not excluded and high-grade squamous intraepithelial lesion interpretations.

Koltz BR, Russell DK, Lu N, Bonfiglio TA, Varghese S

CytoJournal. 2013 10 :6. Epub 03/30/2013.

Dominant TRPV4 mutations in nonlethal and lethal metatropic dysplasia.

Camacho N, Krakow D, Johnykutty S, Katzman PJ, Pepkowitz S, Vriens J, Nilius B, Boyce BF, Cohn DH

American journal of medical genetics. Part A.. 2010 May 152A (5):1169-77. Epub 1900 01 01.

Reduced expression of tocopherol-associated protein (TAP/Sec14L2) in human breast cancer.

Wang X, Ni J, Hsu CL, Johnykutty S, Tang P, Ho YS, Lee CH, Yeh S

Cancer investigation.. 2009 December 27 (10):971-7. Epub 1900 01 01.

Fine-needle aspiration of dedifferentiated acinic cell carcinoma: Report of a case with cyto-histological correlation.

Johnykutty S, Miller CH, Hoda RS, Giampoli EJ

Diagnostic cytopathology.. 2009 October 37 (10):763-8. Epub 1900 01 01.

Dual expression of alpha-tocopherol-associated protein and estrogen receptor in normal/benign human breast luminal cells and the downregulation of alpha-tocopherol-associated protein in estrogen-receptor-positive breast carcinomas.

Johnykutty S, Tang P, Zhao H, Hicks DG, Yeh S, Wang X

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.. 2009 June 22 (6):770-5. Epub 03/20/2009.

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.